Announcements Trials
Browse Landscape

Status

Completed 553Recruiting 266Unknown 156Terminated 132Active not recruiting 117Withdrawn 69Not yet recruiting 64Enrolling by invitation 13Suspended 7Available 3Temporarily not available 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Recurrence 3Myelodysplastic Syndromes 3Precancerous Conditions 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoproliferative Disorders 2Immune System Diseases 2Graft vs Host Disease 2Blast Crisis 2Waldenstrom Macroglobulinemia 1Primary Myelofibrosis 1Preleukemia 1Pancytopenia 1Osteosclerosis 1Osteopetrosis 1Osteochondrodysplasias 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasms 1Myeloproliferative Disorders 1Musculoskeletal Diseases 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Mastocytosis, Systemic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Hematologic Neoplasms × Other hematologic neoplasm × Clear all
NCT02158767 2025-03-12

Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.

Case Comprehensive Cancer Center

No longer available
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡